Insider · CIK 0001930862

Gilson Michelle

Reports to the SEC for 2 companies · SAN JOSE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001930862

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	RANIRani Therapeutics Holdings, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+247K sh	—	—	247,200
2026-04-28	Arcellx, Inc.Performance-based Restricted Stock UnitD Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−59K sh	—	—	0
2026-04-28	Arcellx, Inc.Restricted Stock UnitD Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−88.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−32.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−70.8K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−94.6K sh	—	—	0
2026-04-28	Arcellx, Inc.Restricted Stock UnitD Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−20.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Restricted Stock UnitD Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−61.6K sh	—	—	0
2026-04-28	Arcellx, Inc.Performance-based Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+59K sh	—	—	59,028
2026-04-28	Arcellx, Inc.U Disposition from Tender	CHIEF FINANCIAL OFFICER	UDisposition from Tender	−67K sh	—	—	0
2026-04-28	Arcellx, Inc.U Disposition from Tender	CHIEF FINANCIAL OFFICER	UDisposition from Tender	−5,000 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−40.2K sh	—	—	0
2026-04-16	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,110 sh	$8.66	+$18.3K	67,048
2026-04-16	Arcellx, Inc.Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,110 sh	—	—	40,205
2026-04-15	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+36K sh	$8.66	+$312K	64,938
2026-04-15	Arcellx, Inc.Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−36K sh	—	—	42,315
2026-03-17	Arcellx, Inc.G Gift	CHIEF FINANCIAL OFFICER	GGift	−5,000 sh	—	—	28,938
2026-02-25	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−11.2K sh	$113.82	−$1.28M	33,938
2026-02-19	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,879 sh	$67.73	−$195K	50,662
2026-02-19	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−100 sh	$69.38	−$6,938	45,157
2026-02-19	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−5,405 sh	$68.57	−$371K	45,257
2026-02-17	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−7,141 sh	$69.21	−$494K	57,691
2026-02-17	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−4,150 sh	$70.01	−$291K	53,541
2026-01-06	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+20.5K sh	—	—	64,832
2026-01-06	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+20.5K sh	—	—	64,832
2026-01-06	Arcellx, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−20.5K sh	—	—	61,590
2026-01-03	Arcellx, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−15.3K sh	—	—	0
2026-01-03	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+15.3K sh	—	—	44,302
2026-01-03	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+15.3K sh	—	—	44,302
2026-01-02	Arcellx, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−20.5K sh	—	—	20,496
2026-01-02	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+20.5K sh	—	—	28,962
2026-01-02	Arcellx, Inc.Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+88.5K sh	—	—	88,542
2026-01-02	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+20.5K sh	—	—	28,962
2025-10-15	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−5,364 sh	$91.04	−$488K	8,466
2025-10-06	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,064 sh	$86.22	−$91.7K	13,830
2025-10-03	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−4,882 sh	$86.00	−$420K	14,894
2025-05-27	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−8,449 sh	$64.38	−$544K	19,776
2025-05-27	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,786 sh	$63.62	−$241K	28,225
2025-05-23	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+22.4K sh	—	—	32,011
2025-05-23	Arcellx, Inc.Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−22.4K sh	—	—	0
2025-01-08	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,997 sh	$73.69	−$295K	9,582
2025-01-07	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,327 sh	$77.06	−$179K	18,339
2025-01-07	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−4,760 sh	$75.53	−$360K	13,579
2025-01-07	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,546 sh	$75.23	−$116K	22,917
2025-01-07	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,128 sh	$74.43	−$233K	24,463
2025-01-07	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,251 sh	$76.64	−$173K	20,666
2025-01-06	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−5,621 sh	$77.17	−$434K	27,591
2025-01-06	Arcellx, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−5,102 sh	$77.17	−$394K	28,230
2025-01-06	Arcellx, Inc.Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+82.1K sh	—	—	82,120
2025-01-03	Arcellx, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+15.3K sh	—	—	38,834

Recent filings

Accepted (ET)
Aug 44
Gilson Michelle0001930862-26-000011
SEC(opens sec.gov)
Apr 284
Gilson Michelle0001930862-26-000008
SEC(opens sec.gov)
Apr 174
Gilson Michelle0001193125-26-161748
SEC(opens sec.gov)
Mar 194
Gilson Michelle0001193125-26-116340
SEC(opens sec.gov)
Feb 254
Gilson Michelle0001193125-26-072579
SEC(opens sec.gov)
Feb 194
Gilson Michelle0001193125-26-059840
SEC(opens sec.gov)

Companies

Address

C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE.

SAN JOSE, CA, 95131